The Sichuan Provincial Key Laboratory for Human Disease Gene Study, Prenatal Diagnosis Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Research Unit for Blindness Prevention of Chinese Academy of Medical Sciences (2019RU026), Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China.
Genet Test Mol Biomarkers. 2021 May;25(5):309-316. doi: 10.1089/gtmb.2021.0013. Epub 2021 May 4.
Familial exudative vitreoretinopathy (FEVR) is a blinding retinal vascular disease. Clinically, FEVR is characterized by incomplete vascularization of the peripheral retina and pathological neovascularization. Only about 50% of FEVR cases can be explained by known FEVR disease gene variations. This study aimed to identify novel genes associated with the FEVR phenotype and explore their pathogenic mechanisms. Exome sequencing analyses were conducted on one Chinese family with FEVR whose affected members did not exhibit pathogenic variants in the known FEVR genes (verified using Sanger sequencing analysis). Functions of the affected proteins were evaluated using reporter assays. Western blot analysis was used to detect mutant protein expression and the genes' pathogenic mechanisms. A rare novel heterozygous variant in (c.1792A>G; p.S598G) was identified. The amino acid residues surrounding the identified variant are highly conserved among vertebrates. A luciferase reporter assay revealed that the mutant DLG1 protein DLG1 lost its ability to activate Wnt signaling. Moreover, a knockdown (KD) of in human primary retinal endothelial cells impaired tube formation. Mechanistically, KD led to a reduction in phosphorylated VEGFR2, an essential receptor for the angiogenic potency that signals the vascular endothelial growth factor molecule. The data reported here demonstrate that is a novel candidate gene for FEVR.
家族渗出性玻璃体视网膜病变(FEVR)是一种致盲性视网膜血管疾病。临床上,FEVR 的特征是周边视网膜血管化不完全和病理性新生血管形成。只有约 50%的 FEVR 病例可以用已知的 FEVR 疾病基因突变来解释。本研究旨在鉴定与 FEVR 表型相关的新基因,并探讨其致病机制。对一个具有 FEVR 的中国家族进行外显子组测序分析,该家族的受影响成员在已知的 FEVR 基因中未表现出致病变异(通过 Sanger 测序分析验证)。使用报告基因检测评估受影响蛋白的功能。通过 Western blot 分析检测突变蛋白的表达和基因的致病机制。鉴定出一个罕见的新型杂合变异 (c.1792A>G; p.S598G)。鉴定出的变异周围的氨基酸残基在脊椎动物中高度保守。荧光素酶报告基因检测显示,突变 DLG1 蛋白 DLG1 丧失了激活 Wnt 信号的能力。此外,在人原代视网膜内皮细胞中敲低 (KD) 会损害管腔形成。在机制上,KD 导致磷酸化 VEGFR2 减少,VEGFR2 是血管内皮生长因子分子的血管生成潜力的必需受体。这里报告的数据表明 是 FEVR 的一个新候选基因。